Dexcom (DXCM) — Profile, ISIN & Live Price

Dexcom, Inc. is a prominent American multinational healthcare company specializing in the development and distribution of continuous glucose monitoring (CGM) systems designed to improve diabetes management. With its global headquarters and research and development center located in San Diego, California, Dexcom operates manufacturing facilities in Mesa, Arizona, as well as in Malaysia and Ireland, allowing it to serve a diverse international market. The company's innovative CGM technology provides real-time glucose data, empowering individuals with diabetes to make informed decisions regarding their health and treatment plans.

Recently, Dexcom has reinforced its commitment to expanding the benefits of CGM technology beyond traditional insulin-dependent patients, demonstrating its efficacy in non-insulin diabetes cases and advocating for earlier stage intervention and preventative care. The company is also enhancing its product offerings through strategic initiatives, including the acquisition of wellness tracking company Nutrisense and the launch of the enhanced Stelo app. These developments position Dexcom as a leader in the diabetes management sector, focusing on comprehensive care solutions that cater to a broad population of individuals living with diabetes.